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Chronic diseases such as type 2 diabetes and cardiovascular disease are the leading cause of death and disability worldwide.
Although the metabolic syndrome has been defined in various ways, the ultimate importance of recognizing this combination
of disorders is that it helps identify individuals at high risk for both type 2 diabetes and cardiovascular disease. Evidence from
observational and experimental studies links adverse exposures in early life, particularly relating to nutrition, to chronic disease
susceptibility in adulthood. Such studies provide the foundation and framework for the relatively new field of developmental origins
of health and disease (DOHaD). Although great strides have been made in identifying the putative concepts and mechanisms
relating specific exposures in early life to the risk of developing chronic diseases in adulthood, a complete picture remains obscure.
To date, the main focus of the field has been on perinatal undernutrition and specific nutrient deficiencies; however, the current
global health crisis of overweight and obesity demands that perinatal overnutrition and specific nutrient excesses be examined. This
paper assembles current thoughts on the concepts and mechanisms behind the DOHaD as they relate to maternal nutrition, and
highlights specific contributions made by macro- and micronutrients.

1. Introduction
The metabolic syndrome has become a major public health
challenge with an estimated 22% of US adults having this condition [1]. A consensus group for the International Diabetes
Federation defines metabolic syndrome as central obesity,
plus any two of the following: raised triglycerides, reduced
high-density lipoprotein (HDL) cholesterol, raised fasting
plasma glucose, and raised blood pressure [2]. The consensus group also recommends additional criteria that should
be part of further research into the metabolic syndrome
including tomographic assessment of visceral adiposity and
liver fat, biomarkers of adipose tissue (leptin, adiponectin),
and glucose tolerance testing. The cause of the syndrome
remains obscure but the pathophysiology seems to be largely
attributable to insulin resistance, excessive flux of fatty
acids, and a chronic proinflammatory state [3]. There is

no specific treatment for metabolic syndrome. Therapeutics
include lifestyle changes (e.g., weight reduction and increased
physical activity) and pharmaceutical agents, but prevention
would be preferred. A mounting body of evidence indicates
that certain adverse exposures during the perinatal period
contribute to the development of the metabolic syndrome.
This early life stage may offer an attractive point in the disease
process for prevention and intervention strategies.
In the 1970s Forsdahl, using official statistical data on
Norwegian counties, reported that poverty during adolescence, followed by prosperity, was positively correlated with
risk of death from coronary heart disease [4]. Although
no biological mechanisms were identified, Forsdahl speculated that some form of permanent damage caused by
the nutritional deficit may be involved [4]. In 1986, Barker
and colleagues began publishing reports on the association
between an adverse intrauterine environment, as determined
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primarily by low birth weight, and an increased risk of
coronary heart disease later in life. These studies involved
examining men and women in middle and late life whose
body measurements at birth were recorded in the archives
and records offices of Britain [5, 6]. Upon further investigation, it was found that the correlation between low
birth weight and heart disease was also present between
low birth weight and type 2 diabetes with the prevalence
of impaired glucose tolerance and type 2 diabetes falling
progressively with increasing birth weight [7]. Moreover, in a
follow-up study, an association between birth weight and the
presence of metabolic syndrome was discovered [8]. In this
study metabolic syndrome was defined as impaired glucose
tolerance, hypertension, and elevated triglycerides. In both
men and women, the prevalence of metabolic syndrome fell
progressively with increasing birth weight. Of the 64-year-old
men whose birth weights were 2.95 kg (6.5 pounds) or less,
22% had metabolic syndrome and their risk of developing
the syndrome was more than 10 times greater than that of
men whose birth weights were more than 4.31 kg (9.5 pounds)
[8, 9]. The association between metabolic syndrome and
low birth weight prompted the authors to suggest that the
metabolic syndrome, also called syndrome X, be renamed
“the small-baby syndrome” [8]. Collectively, these studies
generated the Forsdahl-Barker hypothesis, recognizing Forsdahl as the original source of the idea and Barker as the
developer of the concept [10]. In the decades following
their initial publications, the Forsdahl-Barker hypothesis has
become more well known as the “fetal origins” hypothesis
and has produced a new branch of scientific knowledge and
inquiry known as the developmental origins of health and
disease (DOHaD).
Historically, investigations on the fetal origins hypothesis have focused on maternal undernutrition and specific
nutrient deficiencies. Today, the world faces the dual burden of malnutrition that encompasses both under- and
overnutrition [11]. It is estimated that maternal and child
undernutrition is the underlying cause of 3.5 million deaths
globally [12]. While at the same time overweight and obesity
are major public health challenges in both developed and
developing regions of the world. In 2005, 33% of the world’s
adult population (1.3 billion people) was overweight or obese,
and it is estimated that by 2030, up to 57.8% of the world’s
adult population (3.3 billion people) will be overweight or
obese [13]. Adding to the complexity of the dual burden of
malnutrition is the influence of socioeconomic status. By and
large, in developed countries lower socioeconomic status is
associated with both lower birth weights among the offspring
of women and a higher prevalence of obesity among women
[14]. As a result, failure to control for social position could
obscure a relationship between high birth weight and subsequent obesity and obesity-related disorders [15]. Incidentally,
although the vast majority of the literature concerning the
DOHaD is focused on the relationship between small size at
birth and increased incidence of disease in adult life, it is now
recognized that higher incidences of disease occur in both
those born small and those born large, thus reflecting a Ushaped curve [15, 16]. This paper provides a brief overview of
the putative concepts and mechanisms behind the DOHaD
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and assembles thoughts on how alterations in maternal
consumption of specific nutrients may irreversibly direct fetal
programming of the metabolic syndrome (Figure 1).

2. Concepts and Mechanisms
2.1. Developmental Plasticity, Programming, and Mismatch.
For most organs and systems the critical period of plasticity
is during intrauterine development [17]. Developmental plasticity is the ability of an organism to change its phenotype in
response to changes in the environment [18]. If this change or
adaptation is permanent, it is considered a “programming”
change and is associated with persistent effects in structure
and/or function [18, 19]. Programming is an established
biological phenomenon that is exemplified in nature. Gluckman and Hanson use the example of the meadow vole
(Microtus pennsylvanicus) to illustrate programming [16].
Meadow moles born in autumn have a thicker hair coat than
those born in the spring [20]. This occurs as a response of
the fetus to maternally derived signals for day length [21]. A
thick coat reflects an adaptive programming response to help
ensure survival in the cold environment that was predicted
while in utero [16]. Barker uses the functional activity of the
sweat glands to illustrate plasticity and programming [17].
Humans have similar numbers of sweat glands at birth, but
they are essentially nonfunctional. In the first few years of
life a proportion of the glands become functional depending
on the temperature to which the child is exposed. The
hotter the conditions, the greater number of functional sweat
glands. After a few years the process is complete and the
number of functional sweat glands is fixed [17]. Programming
changes can also be experimentally-induced as demonstrated
by examination of adult (100-day-old) female rats that were
given a single subcutaneous injection of testosterone at 2, 5,
10, or 20 days of age [22]. Those that were injected between
birth and 10 days of age had lasting changes in organ weight,
specifically larger adrenal and pituitary weights and smaller
ovarian and uterine weights, as well as absent corpora lutea,
failure to develop normal female sexual behavior, and permanent sterility [22, 23]. Theses aberrations in morphology
and physiology were much reduced or absent in those rats
injected at 10 or 20 days of age, indicating that the period of
plasticity during which rats are androgen sensitive is between
birth and 10 days of age [22].
In most cases programming is beneficial for the health
and survival of the organism. However, the problem of “mismatch” occurs when individuals developmentally adapted
to one environment are exposed to another [24]. Revisiting
the functional activity of the sweat glands to provide an
example, the child who has experienced hot conditions will
be better adapted to such conditions in later life because more
functioning sweat glands provide the ability to cool down
faster. While the child who has experienced cool conditions
faces the problem of mismatch and will be unable to cool
down as easily in hot conditions because of fewer functioning
sweat glands. Other examples of this mismatch phenomenon
include people whose birth weights were towards the lower
end of normal that subsequently grow up in affluent societies
being at increased risk for hypertension, type 2 diabetes, and
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Figure 1: Schematic representation of the relationship between nutrient exposures and the concepts and mechanisms underlying the
developmental origins of health and disease (DOHaD).

cardiovascular disease [16, 25]. The problem of mismatch is
thought to be involved in the current “epidemic” of type 2
diabetes and cardiovascular disease in the young adult and
middle-aged populations of India [26]. Several countries,
including India, are undergoing swift economic and nutritional transitions, exposing individuals to conditions that
promote weight gain [27]. The current surge in metabolic
and cardiovascular disease in India may be being fueled by a
combination of undernutrition in early life and overnutrition
in later life. In a study of Indian children, those born small
and where relatively fat and tall by 8 years of age had the most
adverse risk profiles for cardiovascular disease, including
components of the metabolic syndrome. The authors commented on the possible importance of preventing childhood
obesity in the prevention of disease in the low birth weight
members of the Indian population [26]. It is important to note
that Indians as a race are more prone to the development of
the metabolic syndrome, compared to Caucasians, as a result
of having a phenotype of high fat mass and low lean mass [28].
2.2. Thrifty Phenotype Hypothesis. The “thrifty phenotype”
hypothesis, put forth by Hales and Barker, proposes that poor
fetal and early postnatal nutrition imposes mechanisms of
nutritional thrift upon the growing individual. In conditions
of severe intrauterine deprivation the developing fetus may
lose functional and structural units such as pancreatic 𝛽 cells,
nephrons, and cardiomyocytes [29]. Such changes have been

deemed an adaptive mechanism to ensure the survival of the
fetus. Alternatively, the changes may reflect developmental
malformations analogous to teratogenesis [16]. The thrifty
phenotype hypothesis is based on a study of 468 men in which
the percentage of those with impaired glucose tolerance
or type 2 diabetes fell progressively with increasing birth
weight and weight at 1 year [30]. From this research it was
hypothesized that poor intrauterine nutrition results in the
growth of vital organs, specifically the brain, at the expense
of other organs (i.e., endocrine pancreas resulting in 𝛽 cell
hypoplasia). Such adaptations may increase the chance of
fetal survival by means of “brain sparing” but result in
difficulty in coping with nutritional abundance as an adult.
Interestingly, the thrifty phenotype hypothesis has been
challenged by the “fetal salvage” hypothesis which offers
a different explanation for the insulin resistance seen in
those affected by intrauterine growth restriction [31]. In this
alternate explanation it is not hypoplasia of the pancreatic 𝛽
cells that leads to impaired glucose tolerance, but rather it
is that the fetus develops peripheral insulin resistance. It is
this peripheral insulin resistance that ensures that adequate
amounts of glucose are delivered to essential organs such as
the brain with subsequent reduced delivery to nonessential
tissues such as skeletal muscle. Support for the fetal salvage hypothesis comes from intrauterine growth restriction
studies in rats. In these rodent models, glucose transport
(glucose uptake and glucose transporter mRNA and protein
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levels) is reduced in lung and skeletal muscles of growthrestricted fetuses, whereas glucose transport is unaffected in
brain [32, 33].
The kidney is another organ thought to be affected
by nutritional thrift. In both human and animal studies
small offspring, due to maternal undernutrition and other
causes, have reduced numbers of nephrons which has been
strongly linked to hypertension [16, 34, 35]. In the human,
nephrogenesis is completed in utero, and no new nephrons
are formed after birth; therefore a nephron deficit present at
birth persists throughout life [29, 36]. In a study of human
infants affected by intrauterine growth restriction, nephron
number estimates were below the control group [35]. A
similar study found a 20% reduction in nephron number
in human neonates with low birth weights as compared
to normal birth weight neonates. Additionally, researchers
found a positive relationship between weight at birth and the
number of glomeruli as well as a negative correlation between
weight at birth and glomerular volume [37]. This reduction in
nephrons may reflect an adaptation that has the immediate
advantage of energy and resource conservation but no longterm advantages [16, 34].
2.3. Catch-Up Growth. Catch-up growth, also known as compensatory growth, is where children return to their genetic
trajectory for size after a period of growth delay or arrest.
It may occur at any stage of growth but is most commonly
observed in the first 2 years of life [38]. Studies have found
that catch-up growth often results in overcompensation,
whereby the organism exceeds normal weight and often has
excessive fat deposition. This rapid and excessive growth has
been associated with the development of adult obesity, insulin
resistance, metabolic syndrome, and type 2 diabetes [38–40].
In the Avon Longitudinal Study of Pregnancy and Childhood (ALSPAC) birth cohort, children who showed catchup growth, as calculated by specified gains in standard
deviation scores, between 0 and 2 years of age, were heavier,
taller, and fatter (body mass index, percentage body fat, and
waist circumference) at 5 years of age than other children
[38]. A study that evaluated glucose tolerance and plasma
insulin concentrations in more than 1400 young adults
(26 to 32 years old) who had grown up in the city of Delhi,
India, found an association between thinness in infancy and
the presence of impaired glucose tolerance or diabetes in
young adulthood [41]. As a group, the young adults in the
study who had impaired glucose tolerance or diabetes were
overweight. They were not, however, overweight or obese in
childhood. Instead, they were characterized by their high rate
of gain in body mass after the age of 2 years [41].
Cianfarani and colleagues speculate that the tremendous
effort to recover lost growth shortly after birth involves
insulin and insulin-like growth factors (IGF). Infants affected
by intrauterine growth restriction have low concentrations
of insulin and IGF-1 at birth, and normalization of these
parameters occurs in the postnatal period [42, 43]. It is
thought that tissues chronically depleted of insulin and
IGF-1 throughout fetal life and then suddenly exposed to
increased concentrations of the two hormones shortly after
birth may counteract the actions of insulin by developing
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insulin resistance. Thus, in this proposed scenario, insulin
resistance is serving as a metabolic defense mechanism to
protect the organism against hypoglycemia [39]. In addition
to insulin resistance and type 2 diabetes, accelerated weight
gain in early life has been associated with elevated blood
pressure [44, 45] and coronary heart disease [46].
The implication of catch-up growth is that rapidly
enhancing early childhood growth by a nutrient enriched
diet may cause harm overtime and that encouraging slower
growth rates may actually be beneficial. In a study that provides evidence of the benefits of steady (i.e., not accelerated
by dietary means) growth, investigators measured fasting
concentrations of 32-33 split proinsulin, a marker of insulin
resistance, in adolescents born preterm who had participated
in randomized intervention trials of neonatal nutrition [47].
Fasting 32-33 split proinsulin concentration was greater in
those given a nutrient-enriched diet than those given the
lower-nutrient diet and was associated with greater weight
gain in the first 2 weeks of life [47].
2.4. Oxidative Stress. Excessive reactive oxygen species can
cause modulation of gene expression and/or direct damage
to cell membranes and other molecules at critical developmental windows. Many believe that oxidative stress is
the primary link between adverse fetal growth and later
elevated risks of the metabolic syndrome, type 2 diabetes, and
other disorders [40]. Smoking, hypertension/preeclampsia,
inflammation/infection, obesity, and malnutrition are common causes of preterm and/or low birth weight as well as
known sources of oxidative stress. Malnutrition can directly
lead to a pro-oxidative state by means of creating protein
and micronutrient deficiencies. Proteins provide amino acids
needed for antioxidant synthesis, such as glutathione and
albumin, and many micronutrients themselves are antioxidants, such as vitamins A, C, and E [40, 48]. Pancreatic 𝛽 cells
are particularly sensitive to reactive oxygen species because
they are low in enzymatic antioxidant defense equipment
[49]. It has been demonstrated that oxidative stress can blunt
insulin secretion [50]. With the susceptibility of pancreatic 𝛽
cells to oxidative stress, it is believed that early and ongoing
exposures to oxidative insults could result in the eventual
manifestations of the metabolic syndrome and related disorders [40].
Elevated oxidative stress has been observed among
human infants born small for gestational age (SGA) as
compared to those appropriate for gestational age (AGA) and
among preterm as compared to term infants. It is important
to note that preterm (birth at <37 weeks of pregnancy) infants
are generally of low birth weight but are not necessarily
growth restricted or small for gestational age. A study using
cord blood to compare the status of oxidative stress between
SGA infants born to undernourished mothers and AGA
infants born to healthy mothers found elevated oxidative
stress, as determined by increased quantities of malondialdehyde (one of the major products of lipid peroxidation), reduced quantities of the antioxidant glutathione, and
decreased activity of the antioxidants superoxide dismutase
and catalase in the SGA infants as compared to the AGA
controls [51].
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A human study determined vitamin A, C, and E levels
in the umbilical cord blood of term and preterm infants and
the blood of their mothers taken at the time of delivery [52].
Maternal vitamin A and E levels were higher than cord values,
yet there was a positive correlation between maternal and
cord levels of these two vitamins. Contrary to vitamins A and
E, cord vitamin C levels were higher than maternal levels, and
no significant correlation between cord and maternal vitamin
C levels was present. In comparing vitamin levels in term and
preterm infants, term babies had significantly higher levels of
vitamins A, C, and E. The authors concluded that for vitamins
A and E, neonatal levels are dependent on maternal levels
and that preterm babies have fewer lipid-soluble antioxidant
vitamins in their serum compared to term infants thus may
be more susceptible to oxidative stress [52].
Gestational diabetes, a common cause of macrosomia,
is associated with oxidative stress which could have effects
on the developing infant. A study evaluating oxidative and
antioxidative status in pregnant diabetic (gestational diabetes
or type 1 diabetes) women between 26 and 32 weeks gestation
demonstrated increased oxidative stress in those who were
diabetic [53]. Levels of malondialdehyde were significantly
higher, and vitamin A and E levels were significantly lower
in all diabetic women than controls. Moreover, glutathione
peroxidase and superoxide dismutase activities were significantly reduced in diabetic women; glutathione peroxidase
was reduced in both those with gestational and type 1
diabetes, and superoxide dismutase was reduced only in type
1 diabetics [53].
2.5. Hypothalamic-Pituitary-Adrenal Axis. An increase in
circulating glucocorticoids may play a role in early programming of adult disease. Experimental studies in animals and
epidemiological studies in humans have suggested an altered
set-point of the hypothalamic-pituitary-adrenal (HPA) axis
as an important long-term change that occurs in association
with reduced fetal growth. Pregnant animal models have
shown that exposure to a variety of stressors, including
nutrient restriction, results in the birth of offspring with
elevated basal or stress-induced glucocorticoid secretion [54,
55]. It is thought that maternal exposure to stressors during
pregnancy subsequently leads to excessive fetal exposure to
glucocorticoids resulting in persistent alterations in HPA
axis activity. In support of this hypothesis are studies conducted in rats in which fetoplacental exposure to maternally
administered steroids throughout gestation reduced birth
weight and produced hypertensive adult offspring. In one
such study, dexamethasone administration to pregnant rats
on days 15–20 of gestation resulted in offspring with reduced
birth weight, elevated blood pressure, increased basal plasma
corticosterone, lower mRNA expression of hippocampal
neuronal glucocorticoid receptor, and decreased gene expression of hippocampal mineralocorticoid receptor [56]. In a
sheep study, dams were treated with dexamethasone over 2
days; treatment group 1 was treated during 22–29 days of
pregnancy and treatment group 2 was treated during 59–
66 days of pregnancy (term 145 days) [57]. Offspring from
dams that had received dexamethasone during 22–29 days
gestation, but not days 59–66 of gestation, had elevated
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blood pressures. Such studies suggest that excess glucocorticoid exposure at certain developmental stages or “windows”
programs higher blood pressure [57]. Another study of
pregnant sheep found that severe brief undernutrition in
late gestation altered the function of the HPA axis of adult
offspring. Those exposed to gestational undernourishment
for 10 days demonstrated altered steroid levels including an
increased adrenocorticotropic hormone (ACTH) response as
compared to offspring from dams fed ad libitum or offspring
from dams undernourished for 20 days [58].
An epidemiological study in humans involving three
populations found that adults who had lower birth weights
had elevated fasting plasma concentrations of cortisol and
that cortisol concentrations positively correlated with current
blood pressure [59]. The authors concluded that increased
activity of the HPA axis may link low birth weight with
raised blood pressure in adult life [59]. In a study of over
300 men, plasma cortisol concentrations fell progressively
with increasing birth weight; this trend was independent of
age and body mass index [60]. Raised plasma cortisol concentrations were significantly associated with higher blood
pressure as well as plasma glucose concentrations and insulin
resistance, suggesting that programming of the HPA axis may
be a mechanism underlying the association between low birth
weight and the metabolic syndrome in adult life [60].
2.6. Neuropeptides. The hypothalamus plays a critical role in
the regulation of appetite and body composition by way of
responding to cues from neuropeptides. A series of studies,
primarily in rodents, have explored the possibility that maternal nutrition during pregnancy may alter the level of energy
intake in the offspring through inducing changes in the
hypothalamic circuitry and in the expression, localization,
and action of specific neuropeptides. Central and peripheral neuropeptides function in the regulation of appetite.
Appetite stimulating neuropeptides include neuropeptide Y
(NPY), agouti-related peptide (AgRP), and ghrelin. Conversely, appetite suppressing neuropeptides include cocaine
and amphetamine-related transcript (CART), melanocytestimulating hormone (MSH), serotonin, insulin, and leptin
[61, 62]. Of note is that the overweight and obese tend
to develop resistance to insulin and leptin; therefore these
two neuropeptides are usually elevated in such groups. The
hypothalamus has multiple nerve centers, or nuclei, that are
sensitive to a variety of physiologic changes. Hypothalamic
nuclei include the arcuate nucleus (ARC), paraventricular
nucleus (PVN), and ventromedial nucleus (VMN) which are
involved in a number of biological activities with a fair degree
of overlap [63]. In general, the ARC is a conduit of many
diverse signals involved in various functions such as energy
homeostasis [64], while the PVN is associated with blood
pressure and stress responses [65] and the VMN with satiety
[63]. Each also plays a role in the central nervous system
regulation of food intake and body weight.
Studies in rats have found that exposure to overnutrition
in the fetal or neonatal period can result in permanent
changes in body fat mass and in the hypothalamic neuronal
circuitry regulating appetite in the adult brain. Dörner,
Plagemann, and colleagues found immunocytochemical and
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morphometric aberrations in the hypothalamus of offspring
of diabetic dams or in those exposed to milk from diabetic
dams. In one of their early studies, offspring of diabetic dams
had permanent hypoplasia of the VMN, decreased insulin
responsiveness to glucose, impaired glucose tolerance, and
increased susceptibility to diabetes [66]. A later study examined the effects of exposure to milk from diabetic dams. In
this study, offspring of control dams cross-fostered to diabetic
dams developed early postnatal growth delay and showed
structural and functional hypothalamic “malprogramming”
as it relates to appetite stimulation and suppression [67].
Exposure to milk from a diabetic dam resulted in an upregulation of the appetite stimulants NPY and AgRP and a downregulation of the appetite suppressant MSH. Although the
researchers expected to find changes in the VMN as in their
previous study, they found increased total number of neurons
in the PVN which, as mentioned previously, is associated with
regulation of blood pressure [67]. Incidentally, their research
team performed a human, clinical study and reported an
association between the neonatal ingestion of breast milk
from diabetic mothers and increased blood pressure during
childhood [68].
Leptin has received a considerable amount of attention
in regard to early programming of appetite and body composition. In a rodent study to establish whether neonatal
(postnatal day 3–13) leptin treatment can alleviate postnatal
obesity and the associated metabolic sequelae that occur
in the offspring of undernourished dams, leptin treatment
reversed the programmed phenotype [69]. The benefits of
leptin treatment in these rats included a slowing of neonatal
weight gain and normalized caloric intake, body weight, fat
mass, and fasting plasma glucose and insulin [69]. Studies
in leptin deficient (Lepob /Lepob ) mice have demonstrated
permanently disrupted neural projection pathways from the
ARC [70]. In the adult Lepob /Lepob mice, leptin treatment
did not reverse these neuroanatomical defects; however
treatment of neonatal Lepob /Lepob mice with exogenous
leptin rescued the development of ARC projections [71].
2.7. Epigenetics. Epigenetics refers to all modifications to
genes other than changes in the DNA sequence itself and
includes DNA methylation and histone modifications [18,
72]. DNA methylation is a post-replication modification
that is predominantly found in the cytosines of the dinucleotide sequence cytosine phosphate guanine (CpG) [73].
DNA methylation stabilizes gene expression in cells. Changes
in methylation status (hyper- or hypomethylation) have
been associated with various health conditions including
malignancies [73]. Histones are proteins that permit the
packaging of DNA into nucleosomes, the fundamental units
of chromatin [74]. Histones are subject to a large number of
post-translational modifications which are likely to control
the structure and/or function of the chromatin fiber. Different
modifications may have distinct consequences such as transcriptional activation or DNA repair [74].
Every cell in the body has the same genetic information;
what makes cells, tissues, and organs different is that different
sets of genes are turned on or expressed. An increasing body
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of evidence supports the role of environmentally-induced
epigenetic changes in disease susceptibility. Experimental
studies in agouti mice suggest a role for maternal diet in
inducing epigenetic changes in the offspring [75, 76]. Agouti
mice are so named because they carry the agouti gene
[77]. Those carrying the dominant agouti alleles 𝐴𝑦 or 𝐴𝑣𝑦
develop the complex set of traits collectively referred to
as the yellow obese syndrome. The yellow obese syndrome
encompasses the pleiotropic effects of yellow fur, obesity,
hyperinsulinemia, hyperglycemia, and increased susceptibility to neoplasia [77]. Female a/a mice fed a methylsupplemented diet with extra folate, vitamin B-12, choline,
and betaine 2 weeks prior to mating with male 𝐴𝑣𝑦 /𝑎 agouti
mice and throughout pregnancy and lactation passed along
the agouti gene to their offspring intact, yet demonstrated a
shift in distribution towards having more offspring with the
pseudoagouti phenotype [76]. Pseudoagouti mice are brown,
lean, healthy, and longer lived than their yellow siblings [75].
This shift in the distribution in coat color was mediated
by CpG methylation at the at the 𝐴𝑣𝑦 locus [76]. Another
example of environmentally-induced epigenetic changes is
reduced pancreatic and duodenal homeobox 1 (Pdx1), also
known as insulin promoter factor 1, in a rat model of
intrauterine growth restriction. Pdx1 is a transcription factor necessary for development and function of the insulin
producing pancreatic 𝛽 cell. Rats faced with intrauterine
growth restriction had permanently reduced expression of
Pdx1 in 𝛽 cells and developed type 2 diabetes in adulthood
[78, 79]. Reduced Pdx1 transcription was mediated through
a cascade of epigenetic modifications characterized by loss
of upstream stimulatory factor-1 binding at the proximal
promoter of Pdx1, recruitment of the histone deacetylase 1
and the corepressor Sin3A, and deacetylation of histones H3
and H4 which culminated in the eventual silencing of Pdx1
[78].
The Dutch famine of 1944 has been used by various
investigators as an equivalent to an experimental study to
investigate the effects of perinatal undernutrition in humans
[80]. The ongoing Hunger Winter Families Study contributed
empirical support for the hypothesis that early-life environmental conditions cause epigenetic changes in humans that
persist throughout life. Individuals who had been exposed
to famine during periconception had, 6 decades later, less
DNA methylation of the insulin-like growth factor II (IGF2)
gene compared with their unexposed, same-sex siblings
[81]. The Dutch famine cohort has also been used to study
the transgenerational effects of famine exposure. Women
exposed to famine while in the womb later had offspring with
birth weights lower than offspring of women not exposed to
famine. This effect of in utero exposure to famine on birth
weight in the subsequent generation persisted after control
for potential confounding and intervening variables [82].
In a study of 2 prospective cohorts, Godfrey and colleagues used DNA extracted from umbilical cord tissue
obtained at birth in children who were later assessed for adiposity at 9 years of age to measure methylation status of CpGs
in the promoters of candidate genes [83]. Five candidate genes
were selected based on a number of criteria which included
animal data [83–85] and correlations with overall gene
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methylation status and adiposity. Methylation of retinoid X
receptor-𝛼 (RXRA) chr9: 136355885+ (in cohort 1 and 2) and
endothelial nitric oxide synthase (eNOS) chr7: 150315553+ (in
cohort 1 only) at birth was correlated with greater adiposity
in later childhood. Although the data is correlative and
does not prove causality between DNA methylation at birth
and adiposity in childhood, the observation suggests that
epigenetics is involved in fetal programming of later obesity
[83].

3. Macronutrient Contributions
3.1. Protein. A sizable number of experimental studies,
predominantly in rats, have explored the effects of protein restriction on fetal growth and later health. As discussed in the section on the thrifty phenotype hypothesis, protein restriction during pregnancy has been found
to produce small offspring that have reduced numbers of
nephrons which potentially contributes to the development
of hypertension in adulthood [16, 34, 35]. Low protein
exposure in fetal rats has also been shown to result in
reduced pancreatic 𝛽 cell mass at birth and reduced insulin
secretion in later life presumably due to dietary-induced
reduction in proliferation rate and increased apoptosis of
𝛽 cells [86]. Weanling (26-day-old) rats exposed to low
protein during gestation and lactation were smaller and had
reduced serum insulin and increased serum glucose and
triglycerides [87]. In addition, low protein-exposed offspring
had increased hepatic triglycerides and hepatic expression
of lipogenic enzymes favoring fat synthesis. The authors
suggested that the increased expression of fat-synthesizing
enzymes may account for the increased levels of serum
and liver triglycerides seen in those exposed to low protein
and that these increases may predispose the offspring to
excessive accumulation of fat and ultimately obesity and
insulin resistance [87]. Protein restriction may be involved
in programming food preferences. Rat studies indicate that
gestational exposure to low levels of protein due to maternal
protein restriction establishes a preference for high fat foods
[88]. When given the choice of selecting high fat, high
protein, or high carbohydrate foods, 12-week-old offspring of
dams fed a low protein diet throughout gestation consumed
significantly more of the high fat food and significantly less of
the high carbohydrate food than their control counterparts.
At 30 weeks of age, there was no difference in the pattern of
food selection between the two groups. Their results suggest
that early exposure to undernutrition programs a preference
for fatty foods, and thus maternal nutrition may influence
pathways involved in control of appetite or the perception of
palatability in the offspring [88].
Although the literature on protein restriction and disease risk is quite extensive, it is largely based on rodent
models with few having assessed the specific role of protein
restriction in human risk of disease. One study of men and
women in Scotland sought to determine how diet of the
mother in pregnancy influences blood pressure in the 40year-old adult offspring [89]. The authors found that the
relations between the diet of mothers and the blood pressure
of their offspring were complex. When maternal intake of
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animal protein was less than 50 g daily, a higher carbohydrate
intake was associated with higher blood pressures in the offspring. Conversely, when daily protein intake was above 50 g,
lower carbohydrate intake was associated with higher blood
pressure. An additional finding was that increases in blood
pressure were associated with decreased placental size. Their
conclusions were that blood pressure in adulthood may be
influenced by maternal intakes of protein and carbohydrates
during pregnancy and that this may be mediated through
effects on placental growth [89].
3.2. Carbohydrates. All dietary carbohydrates can be converted into glucose [90]. In both animal and human studies,
intrauterine exposure to high sugar diets and/or hyperglycemia has been found to increase the risk of the metabolic
syndrome. In rats, a high fructose diet for 2 weeks resulted
in increases in systolic blood pressure as well as plasma
insulin and triglyceride concentrations as compared to rats
fed a normal chow [91]. In another rat study early-and longterm exposure to a high sucrose diet (HSD) was assessed to
determine whether such exposure alleviates the detrimental
effects of sucrose feeding in later life [92]. Dams were fed
either standard or HSD (70% calories as sucrose) starting 1
week before breeding and throughout gestation and lactation.
After weaning, all male offspring were fed HSD until the
age of 20 weeks, then detailed metabolic and morphometric
profiles were ascertained. Offspring of sucrose-fed dams
displayed higher adiposity and increases in triglyceride liver
content together with higher low-density lipoprotein (LDL)
cholesterol concentrations. Although the significance and
mechanisms are not clear, a somewhat perplexing observation was that of substantial increases in the insulin sensitivity
of skeletal muscle together with higher concentrations of
adiponectin in the offspring of sucrose-fed dams compared
with the offspring of standard diet-fed dams. Triglycerides,
free fatty acids, overall glucose tolerance, and the insulin
sensitivity of adipose tissue were comparable in both groups
[92].
Data derived from the Camden Study of adolescent
pregnancy implicated high sugar consumption with a twofold
increased risk for delivering small for gestational age infants
[93]. Additionally, evaluation of the data based on ethnicity
led to the detection of a substantial decrease in the duration
of gestation among Puerto Rican adolescents with high sugar
diets, whereas there was no effect of a high sugar diet on
gestation duration among black and white adolescents. The
authors commented that other studies involving comparisons
among ethnicities have found Hispanic women to be more
likely to have abnormalities of carbohydrate metabolism during pregnancy as evidenced by abnormal glucose tolerance
tests and increased incidence of gestational diabetes [93–
95]. Pregnancies complicated by maternal diabetes, in any
form, place the offspring at risk for developing obesity and
glucose intolerance [29, 96]. In a study of 18- to 27-yearold women born to diabetic (gestational diabetes or type 2
diabetes) mothers, the risk of overweight was doubled in
the offspring of diabetic mothers as compared with offspring
from a background population [97]. Moreover, the risk of
the metabolic syndrome was increased 4-fold for offspring of
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mothers with gestational diabetes and 2.5-fold for offspring of
mothers with type 1 diabetes. Offspring risk of the metabolic
syndrome increased significantly with increasing maternal
fasting blood glucose as well as 2-hour blood glucose following an oral glucose load. Their findings indicate that
intrauterine exposure to hyperglycemia contributes to the
pathogenesis of the metabolic syndrome, thus offspring of
diabetic mothers are risk groups for this condition [97].
3.3. Fats. Our laboratory has performed multiple experimental studies aimed at determining the role of high fat diet
in maternal-fetal health. In one such study, mice exposed
to a high saturated fat diet during gestation and lactation
developed adult obesity, hyperglycemia, insulin resistance,
and hypertension, despite being fed a standard rodent diet
post-weaning [98]. Given that oxidative stress is a potential
mechanism connecting fetal exposures to the development
of the metabolic syndrome, a group of pregnant mice were
supplemented with quercetin, a powerful antioxidant, which
mitigated the detrimental effects of high fat diet exposure
[98]. Similarly, Bouanane and colleagues used a rat model
to determine the effects of a cafeteria diet, that had 42%
of energy from fat, on oxidant/antioxidant status as well
as variety of metabolic markers [99]. Dams fed the cafeteria diet developed increased body weight, hyperglycemia,
hyperinsulinemia, hyperleptinemia, hyperlipidemia, and an
imbalance between oxidants/antioxidants favoring oxidative
stress. Male and female offspring displayed similar effects,
which persisted after birth, suggesting an unrelenting effect
of maternal diet on metabolism and body habitus of surviving offspring [99]. In the development of a dietaryinduced gestational diabetes mouse model, our laboratory
demonstrated that consumption of a high saturated fat diet
prior to conception and throughout pregnancy can result in
insulin resistance and placental vascular damage and that
these abnormalities could be a result of oxidative stress [100].
Frias and colleagues, using a nonhuman primate model to
determine the effect of chronic high fat diet on pregnancy
outcome, found that consumption of such a diet, independent
of maternal obesity, led to a significant reduction in uterine
blood flow, a rise in placental inflammation, and an increase
in fetal risk of nonalcoholic fatty liver disease, as evidenced
by increased levels of liver triglycerides and increased hepatic
oxidative stress [101, 102]. Offspring of high fat diet dams
also exhibited elevated hepatic expression of gluconeogenic
enzymes and transcription factors. Moreover, reversing the
maternal high fat diet to a low fat diet during a subsequent
pregnancy improved fetal hepatic triglyceride levels and
partially normalized gluconeogenic enzyme expression. The
authors concluded that a developing fetus is highly vulnerable
to excess lipids, independent of maternal diabetes and/or
obesity and that such exposure may increase the risk of
pediatric fatty liver disease [102].
Human observational studies have also found high fat
intakes to be related to pregnancy and birth outcome as well
as long-term health of the offspring. In a case-control study
of 912 women admitted to obstetric hospitals for spontaneous
abortion, the risk of miscarriage was directly associated with
consumption of the main types of fats, butter and oil, while
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a significant inverse relationship was established between the
risk of spontaneous abortion and the consumption of green
vegetables, fruits, milk, cheese, eggs, and fish [103]. Results
of a comprehensive dietary review of women with a history
of gestational diabetes found that women with recurrence
of gestational diabetes in a subsequent pregnancy had significantly higher fat intakes as a percentage of total energy
than women who did not have recurrence [104]. Lipids and
lipid disorders play a central role in the development of
the metabolic syndrome and its associated diseases [105].
Atherosclerotic lesions are known to begin in early life [106].
Fatty streaks in the aorta have been observed in children as
young as 3 years old [107] and autopsies of young soldiers
killed in the Korean and Vietnam wars revealed advanced
coronary artery lesions [108, 109]. Similarly, the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)
study investigated atherosclerosis in autopsied persons 15 to
34 years old that died from various traumas and observed
advanced lesions of atherosclerosis in adolescents and young
adults and that serum lipoprotein concentrations were a risk
factor [110].

4. Micronutrient Contributions
Although micronutrient deficiencies are known causes of
several well-characterized diseases, such as scurvy and rickets
[111], the role of micronutrients in the fetal origins of adult
disease has yet to be explored in detail. However, existing
evidence points to their potential importance [112]. Many
micronutrients are antioxidants or are components of the
antioxidant defense system. The section on oxidative stress
provided examples on how micronutrients, as antioxidants,
may be associated with various short- and long-term effects
on the offspring. In relating maternal micronutrient intake
with fetal glucocorticoid exposure, a mouse model of maternal dietary restriction of copper, zinc, and vitamin E demonstrated reduced activity level of placental 11𝛽-hydroxysteroid
dehydrogenase-2, an enzyme that protects the fetus from
overexposure to maternal glucocorticoids [113]. As mentioned in the section on the hypothalamic-pituitary-adrenal
axis, fetal exposure to glucocorticoids is associated with
small size at birth and insulin resistance and hypertension
in adult life. Indeed, in this study offspring exposed to
the micronutrient restricted diet had significantly reduced
body weight and crown-to-rump length at birth as well as
increased systolic blood pressure and insulin levels postweaning as compared to those exposed to a control diet. As
discussed in the section on epigenetics, experimental studies
on the impact of methyl-supplemented diets containing
added folate and vitamin B-12 revealed the potential role of
these micronutrients in inducing major changes in offspring
phenotype, including the ability to impact the development of
chronic diseases. Studies on maternal dietary zinc restriction
in rats indicate that zinc deficiency during intrauterine and
postnatal growth can induce elevations in blood pressure
and renal lesions in adulthood [114, 115]. Concerning the
renal alterations identified, early exposure to zinc deficiency
resulted in a decrease in glomerular filtration rate which
was associated with a reduction in the number and size of
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nephrons. These animals also had proteinuria, higher lipid
peroxidation end products, and evidence of increased renal
apoptosis and fibrosis [114, 115].
Few human studies have explored the role of early
micronutrient deficiencies in the development of adult
metabolic disorders. Of the existing reports, results are often
conflicting and the significance is ambiguous. In two randomized controlled trials, both in Nepal, one found that daily
multiple micronutrient supplementation in pregnant women
resulted in slightly lower blood pressure in the offspring at
2.5 years of age [116], while the other found no effects on
blood pressure with maternal multiple micronutrient supplementation among 6- to 8-year-old offspring [117]. As part of
the Pune (India) Maternal Nutrition Study, higher maternal
erythrocyte folate concentrations at 28 weeks gestation were
associated with higher adiposity and insulin resistance in
children 6 years of age [118]. Conversely, a study in England
found that maternal folate intake at 18 or 32 weeks gestation
was not associated with any measures of body composition in
children at 9 years of age [119]. Clearly more work is needed to
disentangle the intricate interactions among micronutrients
and to determine how these interactions may be involved in
the initiation and progression of chronic disease.

5. Conclusions
It is now widely accepted that certain chronic diseases of
adulthood may have their origins in the womb. Studies
discussed in this paper provide evidence that a mother’s diet
during pregnancy can exert major effects on the short- and
long-term health of her children including programming
of the metabolic syndrome. The challenges at present are
to identify common mechanisms and pathways involved
in disparate perinatal malnutrition paradigms, deciphering
physiological and/or pathological roles of specific nutrients,
and to determine which components of the maternal diet
may be best modified to optimize maternal health, placental
integrity, birth outcome, and lifelong health of the offspring.
The implications of this avenue of research, particularly to
obstetric and preventative medicine, dictate that effective
interdisciplinary communication and knowledge transfer
occur and that the information generated is disseminated
to the general public. A recent review provides encouraging
evidence that prenatal nutritional advice appears effective in
reducing the risk of preterm birth and that balanced energy
and protein supplementation seem to improve fetal growth
and may reduce the risk of stillbirth and infants born small
for gestational age [120].
Whilst the evidence in support of the DOHaD is compelling, there are many caveats and controversies in the
field including species differences, body weight verses body
composition, and twin studies. First, species differences
(e.g., maternal age, parity, gestation length, fetal number,
and variability in fetoplacental development) should be
considered when results derived from animal studies are
extrapolated to humans. Rodents are particularly important
to reproductive and obstetric studies because of the strong
similarities between human and murine placentas [121–123];
however, there are many differences between rodents and
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humans particularly relating to early development. Rodents
are altricial species, and their organs mature after birth,
which explains why postnatal factors may be more pertinent in rodent species, whereas pre- and perinatal factors
play a vital role in human development. Human infants
of hyperglycemic mothers develop macrosomia, whereas
hyperglycemic rodent dams typically have normally sized or
small pups. The more precocious human 𝛽 cells produce fetal
insulin prior to birth, thus increasing glucose transport and
growth prenatally, which does not occur in the rodent, whose
endocrine pancreas becomes functional postnatally [62, 124,
125]. Second, studies relating early exposures to later life risk
of disease have been largely based on body weight and/or
body mass index; however, these measurements provide
no information on body composition. More recent studies
have included the assessment of body composition, and
evidence suggests that lower birth weights reflect increased
relative adiposity, while higher birth weights reflect higher
lean mass [15]. The increased use of body composition
analysis is likely to offer a more complete understanding
as to why small babies are prone to the development of
the metabolic syndrome, an association that likely involves
increased adiposity and decreased lean mass at birth. Finally,
studies in twins, especially monozygotic twins, have caused
considerable contention in the field [15, 29]. Twins face
both physical and nutrient constraints and are generally
smaller than singletons. The fetal origins hypothesis indicates
that such individuals should have increased morbidity and
mortality from metabolic and cardiovascular disease, but this
has not been proven to be necessarily the case [15, 29, 126].
The DOHaD is a relatively new field of research and in time
such discrepancies may be resolved. With a more complete
understanding of the role of maternal health and nutrition
in the initiation and progression of the metabolic syndrome
and other disorders comes the hope of prevention of chronic
diseases at their earliest beginnings.
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